Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.

Science Translational Medicine
Miguel ReyesNir Hacohen

Abstract

Bacterial sepsis and severe COVID-19 share similar clinical manifestations and are both associated with dysregulation of the myeloid cell compartment. We previously reported an expanded CD14+ monocyte state, MS1, in patients with bacterial sepsis and validated expansion of this cell subpopulation in publicly available transcriptomics data. Here, using published datasets, we show that the gene expression program associated with MS1 correlated with sepsis severity and was up-regulated in monocytes from patients with severe COVID-19. To examine the ontogeny and function of MS1 cells, we developed a cellular model for inducing CD14+ MS1 monocytes from healthy bone marrow hematopoietic stem and progenitor cells (HSPCs). We found that plasma from patients with bacterial sepsis or COVID-19 induced myelopoiesis in HSPCs in vitro and expression of the MS1 gene program in monocytes and neutrophils that differentiated from these HSPCs. Furthermore, we found that plasma concentrations of IL-6, and to a lesser extent IL-10, correlated with increased myeloid cell output from HSPCs in vitro and enhanced expression of the MS1 gene program. We validated the requirement for these two cytokines to induce the MS1 gene program through CRISPR-Cas9 e...Continue Reading

References

Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia NiemandGerhard Müller-Newen
Sep 28, 2005·The Journal of Experimental Medicine·Paulo C RodriguezAugusto C Ochoa
Dec 22, 2011·JAMA : the Journal of the American Medical Association·Jonathan S BoomerRichard S Hotchkiss
Mar 20, 2012·Journal of Leukocyte Biology·Maya C AndréThorsten W Orlikowsky
Mar 31, 2012·American Journal of Respiratory and Critical Care Medicine·Tamás DolinayAugustine M K Choi
May 4, 2012·Intensive Care Medicine·Marc DeriveSébastien Gibot
Jan 5, 2014·Nature Protocols·Simone PicelliRickard Sandberg
May 6, 2014·Journal of Leukocyte Biology·Javier Cabrera-PerezThomas S Griffith
Jun 15, 2014·Journal of Leukocyte Biology·Helena JanolsKarin Leandersson
Jul 23, 2014·Shock·Anne M DrewryRichard S Hotchkiss
Mar 31, 2015·Nature Methods·Aaron M NewmanAsh A Alizadeh
Apr 25, 2017·Nature Reviews. Immunology·Tom van der PollMihai G Netea
May 2, 2017·Nature Immunology·Thomas UlasDorothee Viemann
May 17, 2017·Oncoimmunology·Annkristin HeinePeter Brossart
Dec 6, 2017·Frontiers in Immunology·Jun DaiMohamed El Gazzar
Jan 20, 2018·Nature Immunology·Filippo VegliaDmitry Gabrilovich
Feb 8, 2018·Genome Biology·F Alexander WolfFabian J Theis
Feb 17, 2018·Nature Communications·Timothy E SweeneyRaymond J Langley
Feb 22, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isaac J JensenVladimir P Badovinac
Apr 25, 2018·Nature Reviews. Nephrology·Christophe Lelubre, Jean-Louis Vincent
May 5, 2018·Nature Reviews. Drug Discovery·Christoph GarbersStefan Rose-John
Oct 12, 2018·Current Protocols in Immunology·Samantha SolitoIlaria Marigo
Dec 13, 2018·American Journal of Respiratory and Critical Care Medicine·Brendon P Scicluna, J Kenneth Baillie
Jun 27, 2019·The Journal of Experimental Medicine·Jérôme MastioDmitry I Gabrilovich

❮ Previous
Next ❯

Citations

Aug 29, 2021·Current Opinion in Virology·Ivan Zanoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.